Latest Regulatory News

Reef Casino Trust has reported a 4.8% increase in revenue and a 6.4% rise in net profit for 2025, supported by strong casino and hotel performance. Meanwhile, a takeover bid at $3.87 per unit is underway, backed by major unitholders and recommended by the board.

Rio Tinto reported solid 2025 results with an 8% increase in copper equivalent production and disciplined cost management, driving a 9% rise in underlying EBITDA to $25.4 billion. The company marked major project completions and maintained a strong dividend payout.

Wrkr Ltd reports a 43% revenue increase to nearly $7 million in H1 FY2026 but also a 75% rise in net loss, while completing a $15 million capital raise and acquiring payroll compliance firm PaidRight.

Arovella Therapeutics reported a 22% increase in half-year losses to $1.88 million while securing FDA acceptance of its IND application for lead asset ALA-101, paving the way for first-in-human trials.

4DS Memory Limited has responded to an ASX price query following a notable rise in its share price and trading volume, confirming no undisclosed information but highlighting ongoing strategic discussions in AI-related technology.

3D Energi Limited has offered 41.7 million free attaching options to investors from its October 2025 Placement, aiming to clear trading restrictions despite ongoing ASX suspension and financial challenges.

Ronin Resources has clarified the cause behind recent unusual trading activity, confirming no undisclosed information and announcing the end of negotiations on a potential copper-gold project in Argentina.

American West Metals Limited reveals a promising Preliminary Economic Analysis for its Storm Copper Project in Canada alongside significant resource growth at its West Desert Project in Utah, positioning itself as a key player in North America's critical metals sector.

DigitalX Limited reports a robust treasury portfolio valued at A$68.2 million, maintaining significant Bitcoin exposure despite a turbulent January in digital asset markets.

Alcidion has secured regulatory approval for its AI-powered clinical tool in Australia and the UK, paving the way for commercial rollout in its largest markets. This milestone strengthens its position in healthcare technology and opens new sales avenues.

BPH Global is nearing completion of its novel seaweed-based men’s health supplement, Project Popeye, as it moves toward TGA listing and scientific validation.

Chariot Resources Ltd has had its trading suspension lifted immediately following the announcement of a new financing arrangement, reopening access for investors.